Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 3, 2003, Pages

  Shigematsu, Takashi ^a   Kono, Takashi ^b   Satoh, Kenichi ^b   Yokoyama, Keitaro ^a   Yoshida, Toyohiko ^b   Hosoya, Tatsuo ^a   Shirai, Kohji ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mihama Hospital   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; End stage renal disease (ESRD); Hyperphosphataemia; Vascular calcification; Vascular smooth muscle cells (VSMCs)

Indexed keywords

CALCIUM; CHOLESTEROL; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTERY CALCIFICATION; ARTERY WALL; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL CALCIFICATION; CELL CULTURE; CELL SECRETION; CELL STIMULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPHOSPHATEMIA; IN VITRO STUDY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RADIAL ARTERY; SCORING SYSTEM; SMOKING; SMOOTH MUSCLE FIBER; THORAX RADIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR SMOOTH MUSCLE;

AORTA, THORACIC; BLOOD VESSELS; CALCIUM; EXTRACELLULAR MATRIX; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHATES; RADIOGRAPHY, THORACIC; RENAL DIALYSIS; TIME FACTORS;

EID: 18144446823     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Muntner P, Coresh J, Klag MJ et al. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors. Am J Kidney Dis 2002; 40: 23-30
2. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 18: 1478-1483
3. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001; 60: 472-479
4. Cozzolino M, Dusso AS, Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001; 12: 2511-2516
5. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
6. Moe SM, O'Neill KD, Duan D et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002; 61: 638-647
7. Shanahan CM, Cary NR, Salisbury JR et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-2176
8. Hofbauer LC, Shui C, Riggs BL et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 280: 334-339
9. Palmer G, Bonjour JP, Caverzasio J. Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology 1997; 138: 5202-5209